159 related articles for article (PubMed ID: 10421269)
1. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study.
Menei P; Venier MC; Gamelin E; Saint-André JP; Hayek G; Jadaud E; Fournier D; Mercier P; Guy G; Benoit JP
Cancer; 1999 Jul; 86(2):325-30. PubMed ID: 10421269
[TBL] [Abstract][Full Text] [Related]
2. Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.
Menei P; Jadaud E; Faisant N; Boisdron-Celle M; Michalak S; Fournier D; Delhaye M; Benoit JP
Cancer; 2004 Jan; 100(2):405-10. PubMed ID: 14716778
[TBL] [Abstract][Full Text] [Related]
3. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma.
Roullin VG; Lemaire L; Venier-Julienne MC; Faisant N; Franconi F; Benoit JP
Anticancer Res; 2003; 23(1A):21-5. PubMed ID: 12680190
[TBL] [Abstract][Full Text] [Related]
4. Implantable drug-releasing biodegradable microspheres for local treatment of brain glioma.
Menei P; Benoit JP
Acta Neurochir Suppl; 2003; 88():51-5. PubMed ID: 14531561
[TBL] [Abstract][Full Text] [Related]
5. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres.
Menei P; Montero-Menei C; Venier MC; Benoit JP
Expert Opin Drug Deliv; 2005 Mar; 2(2):363-76. PubMed ID: 16296760
[TBL] [Abstract][Full Text] [Related]
8. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
10. Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers.
Fournier E; Passirani C; Colin N; Breton P; Sagodira S; Benoit JP
Eur J Pharm Biopharm; 2004 Mar; 57(2):189-97. PubMed ID: 15018974
[TBL] [Abstract][Full Text] [Related]
11. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
Hao X; Cheng G; Zou M; Sun J; Cui F
Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
[TBL] [Abstract][Full Text] [Related]
12. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
[TBL] [Abstract][Full Text] [Related]
15. High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.
Puchner MJ; Giese A; Lohmann F; Cristante L
Anticancer Res; 2004; 24(6):4195-203. PubMed ID: 15736473
[TBL] [Abstract][Full Text] [Related]
16. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R
Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
[TBL] [Abstract][Full Text] [Related]
18. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
[TBL] [Abstract][Full Text] [Related]
20. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
